Metabolic regulation of stem cell function

Journal of Internal Medicine

Volumn 276, Issue 1, 2014, Pages 12-24

  Burgess, R J ^a   Agathocleous, M ^a   Morrison, S J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Differentiation; Metabolism; Self renewal; Stem cell

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE CITRATE SYNTHASE; ALDEHYDE DEHYDROGENASE; AMINO ACID; ANTIOXIDANT; DIOXYGENASE; DNA METHYLTRANSFERASE; FATTY ACID; FLAVINE ADENINE NUCLEOTIDE; FOLIC ACID; HISTONE DEACETYLASE; HISTONE DEMETHYLASE; HISTONE H3; HISTONE LYSINE METHYLTRANSFERASE; HOMOCYSTEINE; ISOCITRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OXYGENASE; PHOSPHOLIPID; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PYROPHOSPHATE; PYRUVATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIRTUIN; TRANSCRIPTION FACTOR; TRICARBOXYLIC ACID; ENZYME;

ADULT STEM CELL; AMINO ACID METABOLISM; ARTICLE; BIOSYNTHESIS; BLASTOCYST; CALORIC RESTRICTION; CELL DIFFERENTIATION; CELL METABOLISM; CELL RENEWAL; CHROMATIN STRUCTURE; CITRIC ACID CYCLE; DNA METHYLATION; ECTODERM; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDODERM; ENERGY YIELD; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; FOLATE METABOLISM; GENE EXPRESSION; GERM CELL; GLYCOLYSIS; HEMATOPOIETIC STEM CELL; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; INTESTINAL STEM CELL; MESODERM; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE METABOLISM; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PHOSPHOLIPID SYNTHESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPHINGOLIPID METABOLISM; STEM CELL; CHROMATIN; DIFFERENTIATION; METABOLISM; NUTRITION; PHYSIOLOGY; REVIEW; SELF-RENEWAL;

DIFFERENTIATION; METABOLISM; SELF-RENEWAL; STEM CELL;

CHROMATIN; ENZYMES; GLYCOLYSIS; HUMANS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OXIDATIVE PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 84906080047     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12247     Document Type: Article

References (126)

1. He S, Nakada D, Morrison SJ. Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol 2009; 25: 377-406.
2. Nishino J, Kim S, Zhu Y, Zhu H, Morrison SJ. A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties. Elife 2013; 2: e00924.
3. Chuikov S, Levi BP, Smith ML, Morrison SJ. Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress. Nat Cell Biol 2010; 12: 999-1006.
4. Goyama S, Yamamoto G, Shimabe M et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 2008; 3: 207-20.
5. Kim I, Saunders TL, Morrison SJ. Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells. Cell 2007; 130: 470-83.
6. Park I, Qian D, Kiel M et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302-5.
7. McMahon KA, Hiew SY-L, Hadjur S et al. Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal. Cell Stem Cell 2007; 1: 338-45.
8. Jude CD, Climer L, Xu D, Artinger E, Fisher JK, Ernst P. Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell 2007; 1: 324-37.
9. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 255-60.
10. Ema H, Sudo K, Seita J et al. Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev Cell 2005; 8: 907-14.
11. Yilmaz OH, Valdez R, Theisen BK et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441: 475-82.
12. Ding L, Morrison SJ. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 2013; 495: 231-5.
13. Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481: 457-62.
14. Joseph C, Quach JM, Walkley CR, Lane SW, Lo Celso C, Purton LE. Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies. Cell Stem Cell 2013; 13: 520-33.
15. Needham J. Chemical Embryology. New York, NY, USA: The MacMillan Company, 1931.
16. Yilmaz ÖH, Katajisto P, Lamming DW et al. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 2012; 486: 490-5.
17. McLeod CJ, Wang L, Wong C, Jones DL. Stem cell dynamics in response to nutrient availability. Curr Biol 2010; 20: 2100-5.
18. O'Brien LE, Bilder D. Beyond the niche: tissue-level coordination of stem cell dynamics. Annu Rev Cell Dev Biol 2013; 29: 107-36.
19. Cerletti M, Jang YC, Finley LWS, Haigis MC, Wagers AJ. Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell 2012; 10: 515-9.
20. Nakada D, Saunders TL, Morrison SJ. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 2010; 468: 653-8.
21. Tothova Z, Kollipara R, Huntly BJ et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007; 128: 325-39.
22. Yu WM, Liu X, Shen J et al. Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell 2013; 12: 62-74.
23. Yanes O, Clark J, Wong DM et al. Metabolic oxidation regulates embryonic stem cell differentiation. Nat Chem Biol 2010; 6: 411-7.
24. Shyh-Chang N, Locasale JW, Lyssiotis CA et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science 2013; 339: 222-6.
25. Wang J, Alexander P, Wu L, Hammer R, Cleaver O, McKnight SL. Dependence of mouse embryonic stem cells on threonine catabolism. Science 2009; 325: 435-9.
26. Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011; 27: 441-64.
27. Ballabeni A, Park I-H, Zhao R et al. Cell cycle adaptations of embryonic stem cells. Proc Natl Acad Sci U S A 2011; 108: 19252-7.
28. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 2007; 4(Suppl 1): S60-7.
29. Zhou W, Choi M, Margineantu D et al. HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J 2012; 31: 2103-16.
30. Birket MJ, Orr AL, Gerencser AA et al. A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells. J Cell Sci 2011; 124: 348-58.
31. Folmes CDL, Nelson TJ, Martinez-Fernandez A et al. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 2011; 14: 264-71.
32. Zhang J, Khvorostov I, Hong JS et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J 2011; 30: 4860-73.
33. Zhu S, Li W, Zhou H et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 2010; 7: 651-5.
34. St John JC, Ramalho-Santos J, Gray HL et al. The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. Cloning Stem Cells 2005; 7: 141-53.
35. Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010; 28: 721-33.
36. Alexander PB, Wang J, McKnight SL. Targeted killing of a mammalian cell based upon its specialized metabolic state. Proc Natl Acad Sci U S A 2011; 108: 15828-33.
37. Casalino L, Comes S, Lambazzi G et al. Control of embryonic stem cell metastability by L-proline catabolism. J Mol Cell Biol 2011; 3: 108-22.
38. Washington JM, Rathjen J, Felquer F et al. L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture. Am J Physiol Cell Physiol 2010; 298: C982-92.
39. Comes S, Gagliardi M, Laprano N et al. L-Proline Induces a Mesenchymal-like Invasive Program in Embryonic Stem Cells by Remodeling H3K9 and H3K36 Methylation. Stem Cell Reports 2013; 1: 307-21.
40. Wang T, Chen K, Zeng X et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 2011; 9: 575-87.
41. DeBerardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell 2012; 148: 1132-44.
42. Kocabas F, Zheng J, Thet S et al. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood 2012; 120: 4963-72.
43. Yeo H, Lyssiotis CA, Zhang Y et al. FoxO3 coordinates metabolic pathways to maintain redox balance in neural stem cells. EMBO J 2013; 32: 2589-602.
44. Agathocleous M, Love NK, Randlett O et al. Metabolic differentiation in the embryonic retina. Nat Cell Biol 2012; 14: 859-64.
45. Simsek T, Kocabas F, Zheng J et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 2010; 7: 380-90.
46. Takubo K, Nagamatsu G, Kobayashi CI et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 2013; 12: 49-61.
47. Parmar K, Mauch P, Vergilio J-A, Sackstein R, Down JD. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 2007; 104: 5431-6.
48. Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011; 9: 298-310.
49. Nombela-Arrieta C, Pivarnik G, Winkel B et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat Cell Biol 2013; 15: 533-43.
50. Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature 2014; 505: 327-34.
51. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148: 399-408.
52. Takubo K, Goda N, Yamada W et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010; 7: 391-402.
53. Rouault-Pierre K, Lopez-Onieva L, Foster K et al. HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress. Cell Stem Cell 2013; 13: 549-63.
54. Mazumdar J, O'Brien WT, Johnson RS et al. O2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol 2010; 12: 1007-13.
55. Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem 2007; 282: 4524-32.
56. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012; 48: 158-67.
57. Signer RAJ, Morrison SJ. Mechanisms that regulate stem cell aging and life span. Cell Stem Cell 2013; 12: 152-65.
58. Kops GJPL, Dansen TB, Polderman PE et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002; 419: 316-21.
59. Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 2005; 24: 7410-25.
60. Yalcin S, Zhang X, Luciano JP et al. Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem 2008; 283: 25692-705.
61. Miyamoto K, Araki KY, Naka K et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007; 1: 101-12.
62. Renault VM, Rafalski VA, Morgan AA et al. FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 2009; 5: 527-39.
63. Paik J, Ding Z, Narurkar R et al. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell 2009; 5: 540-53.
64. Aguilo F, Avagyan S, Labar A et al. Prdm16 is a physiologic regulator of hematopoietic stem cells. Blood 2011; 117: 5057-66.
65. Ito K, Hirao A, Arai F et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004; 431: 997-1002.
66. Allen DM, van Praag H, Ray J et al. Ataxia telangiectasia mutated is essential during adult neurogenesis. Genes Dev 2001; 15: 554-66.
67. Kim J, Wong PKY. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling. Stem Cells 2009; 27: 1987-98.
68. Le Belle JE, Orozco NM, Paucar AA et al. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell 2011; 8: 59-71.
69. Hamanaka RB, Glasauer A, Hoover P et al. Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci Signal 2013; 6: ra8.
70. Juntilla MM, Patil VD, Calamito M, Joshi RP, Birnbaum MJ, Koretzky GA. AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood 2010; 115: 4030-8.
71. Love NR, Chen Y, Ishibashi S et al. Amputation-induced reactive oxygen species are required for successful Xenopus tadpole tail regeneration. Nat Cell Biol 2013; 15: 222-8.
72. Tormos KV, Anso E, Hamanaka RB et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 2011; 14: 537-44.
73. Owusu-Ansah E, Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009; 461: 537-41.
74. Albrecht SC, Barata AG, Grosshans J, Teleman AA, Dick TP. In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab 2011; 14: 819-29.
75. Storms RW, Trujillo AP, Springer JB et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci 1999; 96: 9118-23.
76. Levi BP, Yilmaz OH, Duester G, Morrison SJ. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood 2009; 113: 1670-80.
77. Garaycoechea JI, Crossan GP, Langevin F, Daly M, Arends MJ, Patel KJ. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 2012; 489: 571-5.
78. Langevin F, Crossan GP, Rosado IV, Arends MJ, Patel KJ. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature 2011; 475: 53-8.
79. Gut P, Verdin E. The nexus of chromatin regulation and intermediary metabolism. Nature 2013; 502: 489-98.
80. Cai L, Sutter BM, Li B, Tu BP. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol Cell 2011; 42: 426-37.
81. Cai L, Tu BP. Driving the cell cycle through metabolism. Annu Rev Cell Dev Biol 2012; 28: 59-87.
82. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009; 324: 1076-80.
83. Bracha AL, Ramanathan A, Huang S, Ingber DE, Schreiber SL. Carbon metabolism-mediated myogenic differentiation. Nat Chem Biol 2010; 6: 202-4.
84. Calvanese V, Lara E, Suárez-Alvarez B et al. Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci U S A 2010; 107: 13736-41.
85. Ou X, Chae H-D, Wang R-H et al. SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood 2011; 117: 440-50.
86. Prozorovski T, Schulze-Topphoff U, Glumm R et al. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 2008; 10: 385-94.
87. Brown K, Xie S, Qiu X et al. SIRT3 reverses aging-associated degeneration. Cell Rep 2013; 3: 319-27.
88. Han M-K, Song E-K, Guo Y, Ou X, Mantel C, Broxmeyer HE. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2008; 2: 241-51.
89. Singh SK, Williams CA, Klarmann K, Burkett SS, Keller JR, Oberdoerffer P. Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance. J Exp Med 2013; 210: 987-1001.
90. Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 2012; 13: 225-38.
91. Fulco M, Schiltz RL, Iezzi S et al. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 2003; 12: 51-62.
92. Fulco M, Cen Y, Zhao P et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008; 14: 661-73.
93. Choudhary C, Kumar C, Gnad F et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009; 325: 834-40.
94. Zhao S, Xu W, Jiang W et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010; 327: 1000-4.
95. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10: 295-304.
96. Yuan H-X, Xiong Y, Guan K-L. Nutrient Sensing, Metabolism, and Cell Growth Control. Mol Cell 2013; 49: 379-87.
97. Dang L, White DW, Gross S et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2010; 465: 966.
98. Xu W, Yang H, Liu Y et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 2011; 19: 17-30.
99. Sasaki M, Knobbe CB, Munger JC et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 2012; 488: 656-9.
100. Losman J-A, Looper RE, Koivunen P et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 2013; 339: 1621-5.
101. Lu C, Ward PS, Kapoor GS et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 2012; 483: 474-8.
102. Xiao M, Yang H, Xu W et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 2012; 26: 1326-38.
103. Black JC, Van Rechem C, Whetstine JR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell 2012; 48: 491-507.
104. Hino S, Sakamoto A, Nagaoka K et al. FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nat Commun 2012; 3: 758.
105. Whyte WA, Bilodeau S, Orlando DA et al. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 2012; 482: 221-5.
106. Sprüssel A, Schulte JH, Weber S et al. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia 2012; 26: 2039-51.
107. Kerenyi MA, Shao Z, Hsu Y-J et al. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation. Elife 2013; 2: e00633.
108. Hanover JA, Krause MW, Love DC. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol 2012; 13: 312-21.
109. Sakabe K, Wang Z, Hart GW. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci U S A 2010; 107: 19915-20.
110. Jang H, Kim TW, Yoon S et al. O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network. Cell Stem Cell 2012; 11: 62-74.
111. Shafi R, Iyer SP, Ellies LG et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 2000; 97: 5735-9.
112. Drummond-Barbosa D, Spradling AC. Stem cells and their progeny respond to nutritional changes during Drosophila oogenesis. Dev Biol 2001; 231: 265-78.
113. LaFever L, Drummond-Barbosa D. Direct control of germline stem cell division and cyst growth by neural insulin in Drosophila. Science 2005; 309: 1071-3.
114. Hsu H-J, Drummond-Barbosa D. Insulin levels control female germline stem cell maintenance via the niche in Drosophila. Proc Natl Acad Sci U S A 2009; 106: 1117-21.
115. Chell JM, Brand AH. Nutrition-responsive glia control exit of neural stem cells from quiescence. Cell 2010; 143: 1161-73.
116. Sousa-Nunes R, Yee LL, Gould AP. Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila. Nature 2011; 471: 508-12.
117. Benmimoun B, Polesello C, Waltzer L, Haenlin M. Dual role for Insulin/TOR signaling in the control of hematopoietic progenitor maintenance in Drosophila. Development 2012; 139: 1713-7.
118. Shim J, Mukherjee T, Banerjee U. Direct sensing of systemic and nutritional signals by haematopoietic progenitors in Drosophila. Nat Cell Biol 2012; 14: 394-400.
119. Mair W, Dillin A. Aging and survival: the genetics of life span extension by dietary restriction. Annu Rev Biochem 2008; 77: 727-54.
120. Ertl RP, Chen J, Astle CM, Duffy TM, Harrison DE. Effects of dietary restriction on hematopoietic stem-cell aging are genetically regulated. Blood 2008; 111: 1709-16.
121. O'Brien LE, Soliman SS, Li X, Bilder D. Altered modes of stem cell division drive adaptive intestinal growth. Cell 2011; 147: 603-14.
122. Russell RC, Fang C, Guan K-L. An emerging role for TOR signaling in mammalian tissue and stem cell physiology. Development 2011; 138: 3343-56.
123. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 2010; 40: 310-22.
124. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
125. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
126. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-20.